Medicamen Biotech Limited (NSE:MEDICAMEQ)
India · Delayed Price · Currency is INR 233.00
-4.65 (-1.96%)
Jul 14, 2026, 3:29 PM IST
Medicamen Biotech Market Cap
Medicamen Biotech has a market cap or net worth of 2.96 billion as of July 14, 2026. Its market cap has decreased by -41.35% in one year.
Market Cap
2.96B
Enterprise Value
3.13B
Revenue
2.01B
Ranking
n/a
PE Ratio
30.74
Stock Price
233.00
Market Cap Chart
Since January 12, 2005, Medicamen Biotech's market cap has increased from 108.49M to 2.96B, an increase of 2,631.87%. That is a compound annual growth rate of 16.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 2.96B | -35.79% |
| Dec 31, 2025 | 4.62B | -28.94% |
| Dec 31, 2024 | 6.50B | -14.77% |
| Dec 29, 2023 | 7.62B | -27.09% |
| Dec 30, 2022 | 10.45B | -3.50% |
| Dec 31, 2021 | 10.83B | 86.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Windlas Biotech | 17.13B |
| Jagsonpal Pharmaceuticals | 15.63B |
| Sigachi Industries | 8.66B |
| Bafna Pharmaceuticals | 4.84B |
| Valiant Laboratories | 3.37B |
| Nectar Lifesciences | 2.17B |
| Brooks Laboratories | 2.07B |
| Alpa Laboratories | 1.44B |